 eli lilly ltlly sell elizabeth arden unit eli lilly board decided sell elizabeth arden wholly owned subsidiary manufactures markets cosmetics fine fragrance products business sales 67 mln dlrs acquired 1971 sales year 398 mln dlrs 12 pct 1985 operating profits 33 mln dlrs 1986 lilly retained morgan stanley evaluate offers lilly expects aftertax proceeds sale cosmetics business general corporate purposes including repurchase time time common stock warrants open market statement lilly chairman richard wood strategic decision reached basis belief future corporations resources including research activities focused business high technology life sciences orientation